Portal thrombosis and steatosis after preoperativechemotherapy with FOLFIRI-bevacizumab for colorectal liver metastases

doi:10.3748/wjg.v12.i40.6556

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 40

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2449)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series.

Item

Count

PDF

383

HTML

1816

Figures (1-2)

250

Sum=2449

Oct 28, 2006 (publication date) through Jan 4, 2025

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastroenterol. Oct 28, 2006; 12(40): 6556-6558
Published online Oct 28, 2006. doi: 10.3748/wjg.v12.i40.6556

Full Size Figure Download Figure

Figure 2 Contrast enhanced CT at the level of the portal bifurcation after treatment shows improved hepatic metastasis in segment I (arrowhead), non-visualization of the thrombosed anterior right segmental portal vein (arrow), opacified posterior segmental portal veins, middle and right hepatic veins, and wedge shaped increased enhancement (open arrows) of the anterior sector secondary to portal vein occlusion.

Citation: Donadon M, Vauthey JN, Loyer EM, Charnsangavej C, Abdalla EK. Portal thrombosis and steatosis after preoperativechemotherapy with FOLFIRI-bevacizumab for colorectal liver metastases. World J Gastroenterol 2006; 12(40): 6556-6558
URL: https://www.wjgnet.com/1007-9327/full/v12/i40/6556.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i40.6556